首页|University of Amsterdam Reports Findings in Machine Learning (Unlocking novel therapies: cyclic peptide design for amyloidogenic targets through synergies of experiments, simulations, and machine learning)
University of Amsterdam Reports Findings in Machine Learning (Unlocking novel therapies: cyclic peptide design for amyloidogenic targets through synergies of experiments, simulations, and machine learning)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Machine Learning is the subject of a report. According to newsreporting from Amsterdam, Netherlands, by NewsRx journalists, research stated, “Existing therapies forneurodegenerative diseases like Parkinson’s and Alzheimer’s address only their symptoms and do not preventdisease onset. Common therapeutic agents, such as small molecules and antibodies struggle with insufficientselectivity, stability and bioavailability, leading to poor performance in clinical trials.”
AmsterdamNetherlandsEuropeCyborgsCyclic PeptidesDrugs and TherapiesEmerging TechnologiesMachine LearningPeptides and ProteinsPharmaceuticals
NETL
NSTL
